76 results on '"Cooper, Christopher B"'
Search Results
2. Shape-memory-assisted self-healing of macroscopic punctures via high-energy-density periodic dynamic polymers with tunable actuation temperature
- Author
-
Shi, Yuran, Cooper, Christopher B., Nogusa, Tomoko, Lai, Jian-Cheng, Lyu, Hao, Khatib, Muhammad, Xu, Chengyi, Michalek, Lukas, and Bao, Zhenan
- Abstract
Shape memory polymers (SMPs) show promise in areas like wearable electronics and soft robotics but often have low (actuation) energy densities (<1 MJ/m3), limiting their maximum load. Recent work suggests that periodically incorporating directional H-bonds can enable high-energy-density SMPs by forming stable strain-induced supramolecular nanostructures. Here, we found that adding weaker H-bonding units to the polymer can tune its actuation temperature from 60°C to 25°C while maintaining ∼80% of the energy density of the original polymer and achieving self-healing at accessible temperatures (∼70°C). By using this self-healable, high-energy SMP, we realized rapid healing of macroscopic film damage (e.g., centimeter-sized knife punctures) that was not healable in polymers without high-energy shape-memory-assisted self-healing (SMASH) behavior. The self-healing SMP was used to fabricate a self-healable force sensor with high cyclability and sensitivity, marking a significant advancement in creating tunable and self-healable SMPs for smart, durable wearable devices.
- Published
- 2024
- Full Text
- View/download PDF
3. LungViT: Ensembling Cascade of Texture Sensitive Hierarchical Vision Transformers for Cross-Volume Chest CT Image-to-Image Translation
- Author
-
Chaudhary, Muhammad F. A., Gerard, Sarah E., Christensen, Gary E., Cooper, Christopher B., Schroeder, Joyce D., Hoffman, Eric A., and Reinhardt, Joseph M.
- Abstract
Chest computed tomography (CT) at inspiration is often complemented by an expiratory CT to identify peripheral airways disease. Additionally, co-registered inspiratory-expiratory volumes can be used to derive various markers of lung function. Expiratory CT scans, however, may not be acquired due to dose or scan time considerations or may be inadequate due to motion or insufficient exhale; leading to a missed opportunity to evaluate underlying small airways disease. Here, we propose LungViT– a generative adversarial learning approach using hierarchical vision transformers for translating inspiratory CT intensities to corresponding expiratory CT intensities. LungViT addresses several limitations of the traditional generative models including slicewise discontinuities, limited size of generated volumes, and their inability to model texture transfer at volumetric level. We propose a shifted-window hierarchical vision transformer architecture with squeeze-and-excitation decoder blocks for modeling dependencies between features. We also propose a multiview texture similarity distance metric for texture and style transfer in 3D. To incorporate global information into the training process and refine the output of our model, we use ensemble cascading. LungViT is able to generate large 3D volumes of size
$320\times 320\times320$ - Published
- 2024
- Full Text
- View/download PDF
4. Tunable, reusable, and recyclable perfluoropolyether periodic dynamic polymers with high underwater adhesion strength
- Author
-
Nogusa, Tomoko, Cooper, Christopher B., Yu, Zhiao, Zheng, Yu, Shi, Yuran, and Bao, Zhenan
- Abstract
Most adhesives lose adhesion in the presence of water. Here, hydrophobic perfluoropolyether (PFPE) dynamic polymers with periodically embedded hydrogen bonding units operate as effective underwater adhesives by enhancing van der Waals interactions and minimizing bulk water uptake. Optimizing the bonding interactions in the polymers and their bulk dynamics enables high cohesive strength while maintaining a hydrophobic, nanophase-separated morphology to prevent water-based failure mechanisms. The resulting adhesives have high adhesion strength and can be reversibly applied in fully underwater conditions to polyimide, glass, and steel substrates without any solvent or covalent crosslinking, at room temperature, and without substrate modifications. Moreover, the polymer adhesive can be readily recycled due to the use of dynamic crosslinking to achieve adhesion. This work shows how dynamic PFPE polymers with tunable structures and properties can be designed for high-strength recyclable underwater adhesives, which could enable reversibly attachable and detachable waterproof wearable devices.
- Published
- 2023
- Full Text
- View/download PDF
5. Realizing Intrinsically Stretchable Semiconducting Polymer Films by Nontoxic Additives.
- Author
-
Cheng, Hao-Wen, Zhang, Song, Michalek, Lukas, Ji, Xiaozhou, Luo, Shaochuan, Cooper, Christopher B., Gong, Huaxin, Nikzad, Shayla, Chiong, Jerika A., Wu, Yilei, Zheng, Yu, Liu, Qianhe, Zhong, Donglai, Lei, Yusheng, Tomo, Yoko, Wei, Kung-Hwa, Zhou, Dongshan, Tok, Jeffrey B.-H., and Bao, Zhenan
- Published
- 2022
- Full Text
- View/download PDF
6. Predicting severe chronic obstructive pulmonary disease exacerbations using quantitative CT: a retrospective model development and external validation study
- Author
-
Chaudhary, Muhammad F A, Hoffman, Eric A, Guo, Junfeng, Comellas, Alejandro P, Newell, John D, Nagpal, Prashant, Fortis, Spyridon, Christensen, Gary E, Gerard, Sarah E, Pan, Yue, Wang, Di, Abtin, Fereidoun, Barjaktarevic, Igor Z, Barr, R Graham, Bhatt, Surya P, Bodduluri, Sandeep, Cooper, Christopher B, Gravens-Mueller, Lisa, Han, MeiLan K, Kazerooni, Ella A, Martinez, Fernando J, Menchaca, Martha G, Ortega, Victor E, III, Robert Paine, Schroeder, Joyce D, Woodruff, Prescott G, and Reinhardt, Joseph M
- Abstract
Quantitative CT is becoming increasingly common for the characterisation of lung disease; however, its added potential as a clinical tool for predicting severe exacerbations remains understudied. We aimed to develop and validate quantitative CT-based models for predicting severe chronic obstructive pulmonary disease (COPD) exacerbations.
- Published
- 2023
- Full Text
- View/download PDF
7. Formation Mechanism of Flower-like Polyacrylonitrile Particles.
- Author
-
Gong, Huaxin, Ilavsky, Jan, Kuzmenko, Ivan, Chen, Shucheng, Yan, Hongping, Cooper, Christopher B., Chen, Gan, Chen, Yuelang, Chiong, Jerika A., Jiang, Yuanwen, Lai, Jian-cheng, Zheng, Yu, Stone, Kevin H., Huelsenbeck, Luke, Giri, Gaurav, Tok, Jeffrey B.-H., and Bao, Zhenan
- Published
- 2022
- Full Text
- View/download PDF
8. Embedding Azobenzene-Functionalized Carbon Nanotubes into a Polymer Matrix for Stretchable, Composite Solar Thermal Devices.
- Author
-
Colburn, Thomas W., Delmastro, Alea C., Figueroa, Michael, Lopez, Francisco, and Cooper, Christopher B.
- Published
- 2022
- Full Text
- View/download PDF
9. Association Among Chronic Obstructive Pulmonary Disease Severity, Exacerbation Risk, and Anxiety and Depression Symptoms in the SPIROMICS Cohort
- Author
-
Weiss, Jacob R., Serdenes, Ryan, Madtha, Uchechukwu, Zhao, Huaqing, Kim, Victor, Lopez-Pastrana, Jahaira, Eakin, Michelle N., O'Toole, Jacqueline, Cooper, Christopher B., Woodruff, Prescott, Kanner, Richard E., Krishnan, Jerry A., Iyer, Anand S., Couper, David, and Morrison, Mary F.
- Abstract
Chronic obstructive pulmonary disease (COPD) is a common, progressive lung disease that often manifests with psychiatric symptoms. Despite this, patients with COPD are not routinely screened for anxiety and depression, which substantially contribute to COPD-related morbidity. Objective:To determine the relationship among COPD symptom severity, exacerbation risk, and clinically significant anxiety and depression symptoms in ever smokers with COPD.
- Published
- 2023
- Full Text
- View/download PDF
10. Formation Mechanism of Flower-like Polyacrylonitrile Particles
- Author
-
Gong, Huaxin, Ilavsky, Jan, Kuzmenko, Ivan, Chen, Shucheng, Yan, Hongping, Cooper, Christopher B., Chen, Gan, Chen, Yuelang, Chiong, Jerika A., Jiang, Yuanwen, Lai, Jian-cheng, Zheng, Yu, Stone, Kevin H., Huelsenbeck, Luke, Giri, Gaurav, Tok, Jeffrey B.-H., and Bao, Zhenan
- Abstract
Flower-like polyacrylonitrile (PAN) particles have shown promising performance for numerous applications, including sensors, catalysis, and energy storage. However, the detailed formation process of these unique structures during polymerization has not been investigated. Here, we elucidate the formation process of flower-like PAN particles through a series of in situ and ex situ experiments. We have the following key findings. First, lamellar petals within the flower-like particles were predominantly orthorhombic PAN crystals. Second, branching of the lamellae during the particle formation arose from PAN’s fast nucleation and growth on pre-existing PAN crystals, which was driven by the poor solubility of PAN in the reaction solvent. Third, the particles were formed to maintain a constant center-to-center distance during the reaction. The separation distance was attributed to strong electrostatic repulsion, which resulted in the final particles’ spherical shape and uniform size. Lastly, we employed the understanding of the formation mechanism to tune the PAN particles’ morphology using several experimental parameters including incorporating comonomers, changing temperature, adding nucleation seeds, and adjusting the monomer concentration. These findings provide important insights into the bottom-up design of advanced nanostructured PAN-based materials and controlled polymer nanostructure self-assemblies.
- Published
- 2022
- Full Text
- View/download PDF
11. Embedding Azobenzene-Functionalized Carbon Nanotubes into a Polymer Matrix for Stretchable, Composite Solar Thermal Devices
- Author
-
Colburn, Thomas W., Delmastro, Alea C., Figueroa, Michael, Lopez, Francisco, and Cooper, Christopher B.
- Abstract
Solar thermal batteries allow for on-demand heat release of stored chemical energy. Azobenzene (AB) is a photoactive molecule of particular interest for thermal storage applications due to its ability to absorb ultraviolet light, isomerize to the cisisomer, and release heat upon discharging to the transisomer. In a functioning device, AB requires a substrate matrix to not only stabilize the “charged” cisstate but also provide enough free volume for AB charging and discharging. In this work, we integrate multiwalled carbon nanotubes (MWCNTs) with carboxylic acid patterning and an AB derivative into a stretchable matrix of a styrene-ethylene-butylene-styrene (SEBS) triblock copolymer to create a stretchable, lightweight solar thermal battery. We demonstrate tunable charge and discharge properties based on controlling the SEBS styrene content and the covalent linkage of AB to MWCNTs. Our results illustrate that embedding AB into SEBS sufficiently stabilizes the AB cisstate for energy storage and that the linkage of AB to MWCNTs could provide enhanced absorption for use in ambient solar light.
- Published
- 2022
- Full Text
- View/download PDF
12. Airway mucin MUC5AC and MUC5B concentrations and the initiation and progression of chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort.
- Author
-
Radicioni, Giorgia, Ceppe, Agathe, Ford, Amina A, Alexis, Neil E, Barr, R Graham, Bleecker, Eugene R, Christenson, Stephanie A, Cooper, Christopher B, Han, MeiLan K, Hansel, Nadia N, Hastie, Annette T, Hoffman, Eric A, Kanner, Richard E, Martinez, Fernando J, Ozkan, Esin, Paine III, Robert, Woodruff, Prescott G, O'Neal, Wanda K, Boucher, Richard C, and Kesimer, Mehmet
- Subjects
OBSTRUCTIVE lung diseases ,CHRONIC bronchitis ,PULMONARY function tests ,RESPIRATORY obstructions ,PANEL analysis ,MUCINS - Abstract
We previously described the contributions of increased total airway mucin concentrations to the pathogenesis and diagnosis of the chronic bronchitic component of chronic obstructive pulmonary disease (COPD). Here, we investigated the relative contribution of each of the major airway gel-forming mucins, MUC5AC and MUC5B, to the initiation, progression, and early diagnosis of airways disease in COPD. SPIROMICS was a multicentre, observational study in patients aged 40–80 years recruited from six clinical sites and additional subsites in the USA. In this analysis, MUC5AC and MUC5B were quantitated by stable isotope-labelled mass spectrometry in induced sputum samples from healthy never-smokers, ever-smokers at risk for COPD, and ever-smokers with COPD. Participants were extensively characterised using results from questionnaires, such as the COPD assessment test (CAT) and St George's Respiratory Questionnaire; quantitative CT, such as residual volume/total lung capacity ratio (RV/TLC) and parametric response mapping-functional small airway disease (PRM-fSAD); and pulmonary function tests, such as FEV 1 , forced vital capacity (FVC), and forced expiratory flow, midexpiratory phase (FEF 25–75%). Absolute concentrations of both MUC5AC and MUC5B were related to cross-sectional (baseline, initial visit) and 3-year follow-up longitudinal data, including lung function, small airways obstruction, prospective acute exacerbations, and smoking status as primary outcomes. This study is registered with ClinicalTrials.gov (NCT01969344). This analysis included 331 participants (mean age 63 years [SEM 9·40]), of whom 40 were healthy never-smokers, 90 were at-risk ever-smokers, and 201 were ever-smokers with COPD. Increased MUC5AC concentrations were more reliably associated with manifestations of COPD than were MUC5B concentrations, including decreased FEV 1 and FEF 25–75% , and increased prospective exacerbation frequency, RV/TLC, PRM-fSAD, and COPD assessment scores. MUC5AC concentrations were more reactive to cigarette smoke exposure than were MUC5B concentrations. Longitudinal data from 3-year follow-up visits generated a multivariate-adjusted odds ratio for two or more exacerbations of 1·24 (95% CI 1·04–1·47, p=0·015) for individuals with high baseline MUC5AC concentration. Increased MUC5AC, but not MUC5B, concentration at baseline was a significant predictor of FEV 1 , FEV 1 /FVC, FEF 25–75% , and CAT score decline during the 3-year follow-up. Moreover, current smokers in the at-risk group showed raised MUC5AC concentrations at initial visits and decreased lung function over 3 years. By contrast, former smokers in the at-risk group showed normal MUC5AC concentrations at the initial visit and preserved lung function over 3 years. These data indicate that increased MUC5AC concentration in the airways might contribute to COPD initiation, progression, exacerbation risk, and overall pathogenesis. Compared with MUC5B, greater relative changes in MUC5AC concentrations were observed as a function of COPD severity, and MUC5AC concentration seems to be an objective biomarker to detect disease in at-risk and pre-COPD individuals. These data suggest that MUC5AC-producing pathways could be potential targets for future therapeutic strategies. Thus, MUC5AC could be a novel biomarker for COPD prognosis and for testing the efficacy of therapeutic agents. National Institutes of Health; National Heart, Lung, and Blood Institute. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
13. High Energy Density Shape Memory Polymers Using Strain-Induced Supramolecular Nanostructures.
- Author
-
Cooper, Christopher B., Nikzad, Shayla, Hongping Yan, Yuto Ochiai, Jian-Cheng Lai, Zhiao Yu, Gan Chen, Jiheong Kang, and Zhenan Bao
- Published
- 2021
- Full Text
- View/download PDF
14. Significance of FEV3/FEV6in Recognition of Early Airway Disease in Smokers at Risk of Development of COPD
- Author
-
Yee, Nathan, Markovic, Daniela, Buhr, Russell G., Fortis, Spyridon, Arjomandi, Mehrdad, Couper, David, Anderson, Wayne H., Paine, Robert, Woodruff, Prescott G., Han, Meilan K., Martinez, Fernando J., Barr, R. Graham, Wells, James M., Ortega, Victor E., Hoffman, Eric A., Kim, Victor, Drummond, M. Bradley, Bowler, Russell P., Curtis, Jeffrey L., Cooper, Christopher B., Tashkin, Donald P., and Barjaktarevic, Igor Z.
- Abstract
Small airways are known to be affected early in the course of COPD; however, traditional spirometric indices may not accurately identify small airways disease.
- Published
- 2022
- Full Text
- View/download PDF
15. Airway mucin MUC5AC and MUC5B concentrations and the initiation and progression of chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort
- Author
-
Radicioni, Giorgia, Ceppe, Agathe, Ford, Amina A, Alexis, Neil E, Barr, R Graham, Bleecker, Eugene R, Christenson, Stephanie A, Cooper, Christopher B, Han, MeiLan K, Hansel, Nadia N, Hastie, Annette T, Hoffman, Eric A, Kanner, Richard E, Martinez, Fernando J, Ozkan, Esin, Paine, Robert, Woodruff, Prescott G, O'Neal, Wanda K, Boucher, Richard C, and Kesimer, Mehmet
- Abstract
We previously described the contributions of increased total airway mucin concentrations to the pathogenesis and diagnosis of the chronic bronchitic component of chronic obstructive pulmonary disease (COPD). Here, we investigated the relative contribution of each of the major airway gel-forming mucins, MUC5AC and MUC5B, to the initiation, progression, and early diagnosis of airways disease in COPD.
- Published
- 2021
- Full Text
- View/download PDF
16. Novel Linker Variants of Antileishmanial/Antitubercular 7‑Substituted 2‑Nitroimidazooxazines Offer Enhanced Solubility.
- Author
-
Thompson, Andrew M., O'Connor, Patrick D., Yardley, Vanessa, Maes, Louis, Launay, Delphine, Braillard, Stephanie, Chatelain, Eric, Wan, Baojie, Franzblau, Scott G., Ma, Zhenkun, Cooper, Christopher B., and Denny, William A.
- Published
- 2021
- Full Text
- View/download PDF
17. High Energy Density Shape Memory Polymers Using Strain-Induced Supramolecular Nanostructures
- Author
-
Cooper, Christopher B., Nikzad, Shayla, Yan, Hongping, Ochiai, Yuto, Lai, Jian-Cheng, Yu, Zhiao, Chen, Gan, Kang, Jiheong, and Bao, Zhenan
- Abstract
Shape memory polymers are promising materials in many emerging applications due to their large extensibility and excellent shape recovery. However, practical application of these polymers is limited by their poor energy densities (up to ∼1 MJ/m3). Here, we report an approach to achieve a high energy density, one-way shape memory polymer based on the formation of strain-induced supramolecular nanostructures. As polymer chains align during strain, strong directional dynamic bonds form, creating stable supramolecular nanostructures and trapping stretched chains in a highly elongated state. Upon heating, the dynamic bonds break, and stretched chains contract to their initial disordered state. This mechanism stores large amounts of entropic energy (as high as 19.6 MJ/m3or 17.9 J/g), almost six times higher than the best previously reported shape memory polymers while maintaining near 100% shape recovery and fixity. The reported phenomenon of strain-induced supramolecular structures offers a new approach toward achieving high energy density shape memory polymers.
- Published
- 2021
- Full Text
- View/download PDF
18. Multivalent Assembly of Flexible Polymer Chains into Supramolecular Nanofibers.
- Author
-
Cooper, Christopher B., Kang, Jiheong, Yin, Yikai, Yu, Zhiao, Wu, Hung-Chin, Nikzad, Shayla, Ochiai, Yuto, Yan, Hongping, Cai, Wei, and Bao, Zhenan
- Published
- 2020
- Full Text
- View/download PDF
19. Aspirin Use and Respiratory Morbidity in COPD
- Author
-
Fawzy, Ashraf, Putcha, Nirupama, Aaron, Carrie P., Bowler, Russell P., Comellas, Alejandro P., Cooper, Christopher B., Dransfield, Mark T., Han, MeiLan K., Hoffman, Eric A., Kanner, Richard E., Krishnan, Jerry A., Labaki, Wassim W., Paine, Robert, Paulin, Laura M., Peters, Stephen P., Wise, Robert, Barr, R. Graham, Hansel, Nadia N., Alexis, Neil E., Anderson, Wayne H., Barjaktarevic, Igor, Barr, R. Graham, Bleecker, Eugene R., Boucher, Richard C., Bowler, Russell P., Carretta, Elizabeth E., Christenson, Stephanie A., Comellas, Alejandro P., Cooper, Christopher B., Couper, David J., Criner, Gerard J., Crystal, Ronald G., Curtis, Jeffrey L., Doerschuk, Claire M., Dransfield, Mark T., Freeman, Christine M., Han, MeiLan K., Hansel, Nadia N., Hastie, Annette T., Hoffman, Eric A., Kaner, Robert J., Kanner, Richard E., Kleerup, Eric C., Krishnan, Jerry A., LaVange, Lisa M., Lazarus, Stephen C., Martinez, Fernando J., Meyers, Deborah A., Moore, Wendy C., Newell, John D., Paulin, Laura, Peters, Stephen, Pirozzi, Cheryl, Oelsner, Elizabeth C., O’Neal, Wanda K., Ortega, Victor E., Paine, Robert, Putcha, Nirupama, Raman, Sanjeev, Rennard, Stephen I., Tashkin, Donald P., Wells, J. Michael, Wise, Robert A., and Woodruff, Prescott G.
- Abstract
Aspirin use in COPD has been associated with reduced all-cause mortality in meta-regression analysis with few equivocal studies. However, the effect of aspirin on COPD morbidity is unknown.
- Published
- 2019
- Full Text
- View/download PDF
20. Ratio of FEV1/Slow Vital Capacity of < 0.7 Is Associated With Clinical, Functional, and Radiologic Features of Obstructive Lung Disease in Smokers With Preserved Lung Function
- Author
-
Fortis, Spyridon, Comellas, Alejandro P., Bhatt, Surya P., Hoffman, Eric A., Han, MeiLan K., Bhakta, Nirav R., Paine, Robert, Ronish, Bonnie, Kanner, Richard E., Dransfield, Mark, Hoesterey, Daniel, Buhr, Russell G., Barr, R. Graham, Dolezal, Brett, Ortega, Victor E., Drummond, M. Bradley, Arjomandi, Mehrdad, Kaner, Robert J., Kim, Victor, Curtis, Jeffrey L., Bowler, Russell P., Martinez, Fernando, Labaki, Wassim W., Cooper, Christopher B., O’Neal, Wanda K., Criner, Gerald, Hansel, Nadia N., Krishnan, Jerry A., Woodruff, Prescott, Couper, David, Tashkin, Donald, and Barjaktarevic, Igor
- Abstract
Mild expiratory flow limitation may not be recognized using traditional spirometric criteria based on the ratio of FEV1/FVC.
- Published
- 2021
- Full Text
- View/download PDF
21. The Tuberculosis Drug Accelerator at year 10: what have we learned?
- Author
-
Aldridge, Bree B., Barros-Aguirre, David, Barry, Clifton E., Bates, Robert H., Berthel, Steven J., Boshoff, Helena I., Chibale, Kelly, Chu, Xin-Jie, Cooper, Christopher B., Dartois, Véronique, Duncan, Ken, Fotouhi, Nader, Gusovsky, Fabian, Hipskind, Philip A., Kempf, Dale J., Lelièvre, Joël, Lenaerts, Anne J., McNamara, Case W., Mizrahi, Valerie, Nathan, Carl, Olsen, David B., Parish, Tanya, Petrassi, H. Michael, Pym, Alexander, Rhee, Kyu Y., Robertson, Gregory T., Rock, Jeremy Michael, Rubin, Eric J., Russell, Betsy, Russell, David G., Sacchettini, James C., Schnappinger, Dirk, Schrimpf, Michael, Upton, Anna M., Warner, Peter, Wyatt, Paul Graham, and Yuan, Ying
- Abstract
The Tuberculosis Drug Accelerator, an experiment designed to facilitate collaboration in tuberculosis drug discovery by breaking down barriers among competing labs and institutions, has reached a 10-year landmark. We review the consortium’s achievements, advantages and limitations and advocate for the application of similar models to other diseases.
- Published
- 2021
- Full Text
- View/download PDF
22. Clinical Phenotypes of Atopy and Asthma in COPD
- Author
-
Putcha, Nirupama, Fawzy, Ashraf, Matsui, Elizabeth C., Liu, Mark C., Bowler, Russ P., Woodruff, Prescott G., O’Neal, Wanda K., Comellas, Alejandro P., Han, MeiLan K., Dransfield, Mark T., Wells, J. Michael, Lugogo, Njira, Gao, Li, Talbot, C. Conover, Hoffman, Eric A., Cooper, Christopher B., Paulin, Laura M., Kanner, Richard E., Criner, Gerard, Ortega, Victor E., Barr, R. Graham, Krishnan, Jerry A., Martinez, Fernando J., Drummond, M. Bradley, Wise, Robert A., Diette, Gregory B., Hersh, Craig P., and Hansel, Nadia N.
- Abstract
Little is known about the concordance of atopy with asthma COPD overlap. Among individuals with COPD, a better understanding of the phenotypes characterized by asthma overlap and atopy is needed to better target therapies.
- Published
- 2020
- Full Text
- View/download PDF
23. Multivalent Assembly of Flexible Polymer Chains into Supramolecular Nanofibers
- Author
-
Cooper, Christopher B., Kang, Jiheong, Yin, Yikai, Yu, Zhiao, Wu, Hung-Chin, Nikzad, Shayla, Ochiai, Yuto, Yan, Hongping, Cai, Wei, and Bao, Zhenan
- Abstract
Polymeric materials in nature regularly employ ordered, hierarchical structures in order to perform unique and precise functions. Importantly, these structures are often formed and stabilized by the cooperative summation of many weak interactions as opposed to the independent association of a few strong bonds. Here, we show that synthetic, flexible polymer chains with periodically placed and directional dynamic bonds collectively assemble into supramolecular nanofibers when the overall molecular weight is below the polymer’s critical entanglement molecular weight. This causes bulk films of long polymer chains to have faster dynamics than films of shorter polymer chains of identical chemical composition. The formation of nanofibers increases the bulk film modulus by over an order of magnitude and delays the onset of terminal flow by more than 100 °C, while still remaining solution processable. Systematic investigation of different polymer chain architectures and dynamic bonding moieties along with coarse-grained molecular dynamics simulations illuminate governing structure–function relationships that determine a polymer’s capacity to form supramolecular nanofibers. This report of the cooperative assembly of multivalent polymer chains into hierarchical, supramolecular structures contributes to our fundamental understanding of designing biomimetic functional materials.
- Published
- 2020
- Full Text
- View/download PDF
24. Associations Among 25-Hydroxyvitamin D Levels, Lung Function, and Exacerbation Outcomes in COPD
- Author
-
Burkes, Robert M., Ceppe, Agathe S., Doerschuk, Claire M., Couper, David, Hoffman, Eric A., Comellas, Alejandro P., Barr, R. Graham, Krishnan, Jerry A., Cooper, Christopher, Labaki, Wassim W., Ortega, Victor E., Wells, J. Michael, Criner, Gerard J., Woodruff, Prescott G., Bowler, Russell P., Pirozzi, Cheryl S., Hansel, Nadia N., Wise, Robert A., Brown, Todd T., Drummond, M. Bradley, Alexis, Neil E., Anderson, Wayne H., Arjomandi, Mehrdad, Barjaktarevic, Igor, Barr, R. Graham, Bateman, Lori A., Bhatt, Surya P., Bleecker, Eugene R., Boucher, Richard C., Bowler, Russell P., Christenson, Stephanie A., Comellas, Alejandro P., Cooper, Christopher B., Couper, David J., Criner, Gerard J., Crystal, Ronald G., Curtis, Jeffrey L., Doerschuk, Claire M., Dransfield, Mark T., Drummond, Brad, Freeman, Christine M., Galban, Craig, Han, MeiLan K., Hansel, Nadia N., Hastie, Annette T., Hoffman, Eric A., Huang, Yvonne, Kaner, Robert J., Kanner, Richard E., Kleerup, Eric C., Krishnan, Jerry A., LaVange, Lisa M., Lazarus, Stephen C., Martinez, Fernando J., Meyers, Deborah A., Moore, Wendy C., Newell, John D., Paine, Robert, Paulin, Laura, Peters, Stephen P., Pirozzi, Cheryl, Putcha, Nirupama, Oelsner, Elizabeth C., O’Neal, Wanda K., Ortega, Victor E., Raman, Sanjeev, Rennard, Stephen I., Tashkin, Donald P., Wells, J. Michael, Wise, Robert A., Woodruff, Prescott G., Postow, Lisa, and Viviano, Lisa
- Abstract
The relationship between 25-hydroxyvitamin D (25-OH-vitamin D) and COPD outcomes remains unclear. Using the Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS), we determined associations among baseline 25-OH-vitamin D and cross-sectional and longitudinal lung function and COPD exacerbations.
- Published
- 2020
- Full Text
- View/download PDF
25. Structural and Functional Features on Quantitative Chest Computed Tomography in the Korean Asian versus the White American Healthy Non-Smokers.
- Author
-
Hyun Bin Cho, Kum Ju Chae, Gong Yong Jin, Jiwoong Choi, Ching-Long Lin, Hoffman, Eric A., Wenzel, Sally E., Castro, Mario, Fain, Sean B., Jarjour, Nizar N., Schiebler, Mark L., Barr, R. Graham, Hansel, Nadia, Cooper, Christopher B., Kleerup, Eric C., Han, MeiLan K., Woodruff, Prescott G., Kanner, Richard E., Bleecker, Eugene R., and Peters, Stephen P.
- Published
- 2019
- Full Text
- View/download PDF
26. Cosensitization in Dye-Sensitized Solar Cells.
- Author
-
Cole, Jacqueline M., Pepe, Giulio, Al Bahri, Othman K., and Cooper, Christopher B.
- Published
- 2019
- Full Text
- View/download PDF
27. Heart Rate Acquisition and Threshold-Based Training Increases Oxygen Uptake at Metabolic Threshold in Triathletes: A Pilot Study.
- Author
-
NEUFELD, ERIC V., WADOWSKI, JEREMY, BOLAND, DAVID M., DOLEZAL, BRETT A., and COOPER, CHRISTOPHER B.
- Subjects
HEART beat ,AEROBIC capacity ,ANAEROBIC threshold ,EXERCISE intensity ,TRIATHLETES ,RUNNING ,CYCLING - Abstract
International Journal of Exercise Science 12(2): 144-154, 2019. Exercise intensity is a critical component of the exercise prescription model. However, current research employing various non-specific exercise intensity protocols have reported wide variability in maximum oxygen uptake (VO
2max ) improvement after training, suggesting a present lack of consensus regarding optimal heart rate (fC) training zones for maximal athletic performance. This study examined the relationship between percentage of time (%time) spent training between the metabolic (VO2 θ) and ventilatory thresholds (VE θ), and the resultant change in markers of aerobic performance. Thirteen (6 males) collegiate club-level triathletes were recruited for eight weeks of remote fC monitoring during all running and cycling sessions. Participants donned a forearm-worn optical fC sensor paired to a smartphone that collected and stored fCs. Subjects were categorized into Low and High groups based on %time spent training between the VO2 θ and VE θ. Significant increases were observed in relative VO2max (P = 0.007, g = 0.48), VO2 θ (P = 0.018, g = 0.35), and VE θ (P = 0.030, g = 0.29) from baseline after eight weeks for both groups. A 95% bootstrapped confidence interval that did not include zero (-0.38, -0.03; g = 1.26) revealed a large and significantly greater change in VO2 θ in the High group (0.37 ± 0.15 L/min) versus the Low group (0.17 ± 0.14 L/min). No significant differences were observed in other variables between groups. Increasing triathletes' %time spent exercising between VO2 θ and VE θ may optimize increases in VO2 θ after eight weeks of training. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
28. COMPUTER-ASSISTED QUANTITATIVE IMAGE ANALYSIS FOR IDENTIFICATION OF PULMONARY FIBROSIS AND EMPHYSEMA: PATHWAY TO CHARACTERIZING CPFE
- Author
-
HOESTEREY, DANIEL, HYUN KIM, GRACE, LEE, JIHEY, OH, ANDREA, POURZAND, LILA, GOLDIN, JONATHAN G, HOFFMAN, ERIC A, WANG, JENNIFER, HAN, MEILAN K, COOPER, CHRISTOPHER B, TASHKIN, DONALD P, BARJAKTAREVIC, IGOR, and ABTIN, FEREIDOUN
- Published
- 2023
- Full Text
- View/download PDF
29. Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort
- Author
-
Hastie, Annette T, Martinez, Fernando J, Curtis, Jeffrey L, Doerschuk, Claire M, Hansel, Nadia N, Christenson, Stephanie, Putcha, Nirupama, Ortega, Victor E, Li, Xingnan, Barr, R Graham, Carretta, Elizabeth E, Couper, David J, Cooper, Christopher B, Hoffman, Eric A, Kanner, Richard E, Kleerup, Eric, O'Neal, Wanda K, Paine, Richard, Peters, Stephen P, Alexis, Neil E, Woodruff, Prescott G, Han, MeiLan K, Meyers, Deborah A, Bleecker, Eugene R, Alexis, Neil E, Anderson, Wayne H, Barr, R Graham, Bleecker, Eugene R, Boucher, Richard C, Bowler, Russell P, Carretta, Elizabeth E, Christenson, Stephanie A, Comellas, Alejandro P, Cooper, Christopher B, Couper, David J, Criner, Gerard J, Crystal, Ronald G, Curtis, Jeffrey L, Doerschuk, Claire M, Dransfield, Mark T, Freeman, Christine M, Han, MeiLan K, Hansel, Nadia N, Hastie, Annette T, Hoffman, Eric A, Kaner, Robert J, Kanner, Richard E, Kleerup, Eric C, Krishnan, Jerry A, LaVange, Lisa M, Lazarus, Stephen C, Martinez, Fernando J, Meyers, Deborah A, Newell, John D, Oelsner, Elizabeth C, O'Neal, Wanda K, Paine, Robert, Putcha, Nirupama, Rennard, Stephen I., Tashkin, Donald P, Scholand, Mary Beth, Wells, J Michael, Wise, Robert A, and Woodruff, Prescott G
- Abstract
Increased concentrations of eosinophils in blood and sputum in chronic obstructive pulmonary disease (COPD) have been associated with increased frequency of exacerbations, reduced lung function, and corticosteroid responsiveness. We aimed to assess whether high eosinophil concentrations in either sputum or blood are associated with a severe COPD phenotype, including greater exacerbation frequency, and whether blood eosinophils are predictive of sputum eosinophils.
- Published
- 2017
- Full Text
- View/download PDF
30. Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort
- Author
-
Han, MeiLan K, Quibrera, Pedro M, Carretta, Elizabeth E, Barr, R Graham, Bleecker, Eugene R, Bowler, Russell P, Cooper, Christopher B, Comellas, Alejandro, Couper, David J, Curtis, Jeffrey L, Criner, Gerard, Dransfield, Mark T, Hansel, Nadia N, Hoffman, Eric A, Kanner, Richard E, Krishnan, Jerry A, Martinez, Carlos H, Pirozzi, Cheryl B, O'Neal, Wanda K, Rennard, Stephen, Tashkin, Donald P, Wedzicha, Jadwiga A, Woodruff, Prescott, Paine, Robert, Martinez, Fernando J, Alexis, Neil E, Anderson, Wayne H, Barr, R Graham, Bleecker, Eugene R, Boucher, Richard C, Bowler, Russell P, Carretta, Elizabeth E, Christenson, Stephanie A, Comellas, Alejandro P, Cooper, Christopher B, Couper, David J, Criner, Gerard J, Crystal, Ronald G, Curtis, Jeffrey L, Doerschuk, Claire M, Dransfield, Mark T, Freeman, Christine M, Han, MeiLan K, Hansel, Nadia N, Hastie, Annette T, Hoffman, Eric A, Kaner, Robert J, Kanner, Richard E, Kleerup, Eric C, Krishnan, Jerry A, LaVange, Lisa M, Lazarus, Stephen C, Martinez, Fernando J, Meyers, Deborah A, Newell, John D, Oelsner, Elizabeth C, O'Neal, Wanda K, Paine, Robert, Putcha, Nirupama, Rennard, Stephen I., Tashkin, Donald P, Scholand, Mary Beth, Wells, J Michael, Wise, Robert A, and Woodruff, Prescott G
- Abstract
Present treatment strategies to stratify exacerbation risk in patients with chronic obstructive pulmonary disease (COPD) rely on a history of two or more events in the previous year. We aimed to understand year to year variability in exacerbations and factors associated with consistent exacerbations over time.
- Published
- 2017
- Full Text
- View/download PDF
31. Association of Long-term Ambient Ozone Exposure With Respiratory Morbidity in Smokers
- Author
-
Paulin, Laura M., Gassett, Amanda J., Alexis, Neil E., Kirwa, Kipruto, Kanner, Richard E., Peters, Stephen, Krishnan, Jerry A., Paine, Robert, Dransfield, Mark, Woodruff, Prescott G., Cooper, Christopher B., Barr, R. Graham, Comellas, Alejandro P., Pirozzi, Cheryl S., Han, MeiLan, Hoffman, Eric A., Martinez, Fernando J., Woo, Han, Peng, Roger D., Fawzy, Ashraf, Putcha, Nirupama, Breysse, Patrick N., Kaufman, Joel D., and Hansel, Nadia N.
- Abstract
IMPORTANCE: Few studies have investigated the association of long-term ambient ozone exposures with respiratory morbidity among individuals with a heavy smoking history. OBJECTIVE: To investigate the association of historical ozone exposure with risk of chronic obstructive pulmonary disease (COPD), computed tomography (CT) scan measures of respiratory disease, patient-reported outcomes, disease severity, and exacerbations in smokers with or at risk for COPD. DESIGN, SETTING, AND PARTICIPANTS: This multicenter cross-sectional study, conducted from November 1, 2010, to July 31, 2018, obtained data from the Air Pollution Study, an ancillary study of SPIROMICS (Subpopulations and Intermediate Outcome Measures in COPD Study). Data analyzed were from participants enrolled at 7 (New York City, New York; Baltimore, Maryland; Los Angeles, California; Ann Arbor, Michigan; San Francisco, California; Salt Lake City, Utah; and Winston-Salem, North Carolina) of the 12 SPIROMICS clinical sites. Included participants had historical ozone exposure data (n = 1874), were either current or former smokers (≥20 pack-years), were with or without COPD, and were aged 40 to 80 years at baseline. Healthy persons with a smoking history of 1 or more pack-years were excluded from the present analysis. EXPOSURES: The 10-year mean historical ambient ozone concentration at participants’ residences estimated by cohort-specific spatiotemporal modeling. MAIN OUTCOMES AND MEASURES: Spirometry-confirmed COPD, chronic bronchitis diagnosis, CT scan measures (emphysema, air trapping, and airway wall thickness), 6-minute walk test, modified Medical Research Council (mMRC) Dyspnea Scale, COPD Assessment Test (CAT), St. George’s Respiratory Questionnaire (SGRQ), postbronchodilator forced expiratory volume in the first second of expiration (FEV1) % predicted, and self-report of exacerbations in the 12 months before SPIROMICS enrollment, adjusted for demographics, smoking, and job exposure. RESULTS: A total of 1874 SPIROMICS participants were analyzed (mean [SD] age, 64.5 [8.8] years; 1479 [78.9%] white; and 1013 [54.1%] male). In adjusted analysis, a 5-ppb (parts per billion) increase in ozone concentration was associated with a greater percentage of emphysema (β = 0.94; 95% CI, 0.25-1.64; P = .007) and percentage of air trapping (β = 1.60; 95% CI, 0.16-3.04; P = .03); worse scores for the mMRC Dyspnea Scale (β = 0.10; 95% CI, 0.03-0.17; P = .008), CAT (β = 0.65; 95% CI, 0.05-1.26; P = .04), and SGRQ (β = 1.47; 95% CI, 0.01-2.93; P = .048); lower FEV1% predicted value (β = −2.50; 95% CI, −4.42 to −0.59; P = .01); and higher odds of any exacerbation (odds ratio [OR], 1.37; 95% CI, 1.12-1.66; P = .002) and severe exacerbation (OR, 1.37; 95% CI, 1.07-1.76; P = .01). No association was found between historical ozone exposure and chronic bronchitis, COPD, airway wall thickness, or 6-minute walk test result. CONCLUSIONS AND RELEVANCE: This study found that long-term historical ozone exposure was associated with reduced lung function, greater emphysema and air trapping on CT scan, worse patient-reported outcomes, and increased respiratory exacerbations for individuals with a history of heavy smoking. The association between ozone exposure and adverse respiratory outcomes suggests the need for continued reevaluation of ambient pollution standards that are designed to protect the most vulnerable members of the US population.
- Published
- 2020
- Full Text
- View/download PDF
32. Systemic Markers of Inflammation in Smokers With Symptoms Despite Preserved Spirometry in SPIROMICS
- Author
-
Garudadri, Suresh, Woodruff, Prescott G., Han, MeiLan K., Curtis, Jeffrey L., Barr, R. Graham, Bleecker, Eugene R., Bowler, Russell P., Comellas, Alejandro, Cooper, Christopher B., Criner, Gerard, Dransfield, Mark T., Hansel, Nadia N., Paine, Robert, Krishnan, Jerry A., Peters, Stephen P., Hastie, Annette T., Martinez, Fernando J., O'Neal, Wanda K., Couper, David J., Alexis, Neil E., and Christenson, Stephanie A.
- Abstract
Chronic respiratory symptoms and exacerbation-like events are common among ever-smokers without airflow limitation on spirometry. The pathobiology of respiratory disease in this subgroup remains poorly defined, but may be due to underlying inflammation that overlaps with COPD or asthma. We hypothesized that symptoms, exacerbations, and functional measures of disease severity among smokers with preserved spirometry would be associated with markers of systemic inflammation, similar to what is reported in bone fide COPD, rather than elevated type 2 inflammation, which is often present in asthma.
- Published
- 2019
- Full Text
- View/download PDF
33. Network Evolution Controlling Strain-Induced Damage and Self-Healing of Elastomers with Dynamic Bonds
- Author
-
Yin, Yikai, Mohanty, Shaswat, Cooper, Christopher B., Bao, Zhenan, and Cai, Wei
- Abstract
Highly stretchable and self-healable supramolecular elastomers are promising materials for future soft electronics, biomimetic systems, and smart textiles, due to their dynamic cross-linking bonds. The dynamic or reversible nature of the cross-links gives rise to interesting macroscopic responses in these materials such as self-healing and rapid stress-relaxation. However, the relationship between bond activity and macroscopic mechanical response, and the self-healing properties of these dynamic polymer networks (DPNs) remains poorly understood. Using coarse-grained molecular dynamics (CGMD) simulations, we reveal a fundamental connection between the macroscopic behaviors of DPNs and the shortest paths between distant nodes in the polymer network. Notably, the trajectories of the material on the shortest path-strain map provide key insights into understanding the stress–strain hysteresis, anisotropy, stress relaxation, and self-healing of DPNs. Based on CGMD simulations under various loading histories, we formulate a set of empirical rules that dictate how the shortest path interacts with stress and strain. This lays the foundation for the development of a physics-based theory centered around the nonlocal microstructural feature of shortest paths to predict the mechanical behavior of DPNs.
- Published
- 2024
- Full Text
- View/download PDF
34. Alveolar eosinophilia in current smokers with chronic obstructive pulmonary disease in the SPIROMICS cohort.
- Author
-
Martinez, Carlos H., Li, Sara X., Hirzel, Andrew J., Stolberg, Valerie R., Alexis, Neil E., Barr, R. Graham, Bleecker, Eugene R., Carretta, Elizabeth E., Christenson, Stephanie A., Cooper, Christopher B., Couper, David J., Doerschuk, Claire M., Han, MeiLan K., Hansel, Nadia N., Hastie, Annette T., Hoffman, Eric A., Kaner, Robert J., Martinez, Fernando J., Meyers, Deborah A., and O'Neal, Wanda K.
- Published
- 2018
- Full Text
- View/download PDF
35. Wrist-worn triaxial accelerometry predicts the energy expenditure of non-vigorous daily physical activities.
- Author
-
Sirichana, Worawan, Dolezal, Brett A., Neufeld, Eric V., Wang, Xiaoyan, and Cooper, Christopher B.
- Abstract
Objectives: Triaxial accelerometry is commonly used to estimate oxygen uptake (VO2) and energy expenditure in health and fitness studies. We tested the correlation of a triaxial accelerometer in terms of a summation of vector magnitudes with gravity subtracted (SVMgs) and measured VO2 for different daily physical activities.Design: Original research, cross-sectional.Methods: Twenty volunteers wore a triaxial accelerometer on both wrists while performing 12 assigned daily physical activities for 6min for each activity. The VO2 was determined by indirect calorimetry using a portable metabolic measurement system. The last 3min of each activity was assumed to represent steady-state. The VO2 measured during these periods was averaged and converted into metabolic equivalents (METs).Results: The range of VO2 for all activities was 0.18-3.2L/min (0.8-12.2 METs). Significant differences in SVMgs existed between accelerometer placements on the dominant (120.9±8.7gmin) versus non-dominant hand (99.9±6.8gmin; P=0.016) for the lowest levels of physical activity defined as <1.5 METs. Piecewise linear regression model using 6 METs as the transition point showed similar significant correlations for the non-dominant wrist (r2=0.85; P<0.001) and the dominant wrist (r2=0.86; P<0.001). Using the non-dominant wrist below 6 METs, the slope of the relationship between SVMgs and METs was 105.3±4.3 (95% CI 96.9 to 113.7) indicating an increase in SVMgs of approximately 100 units for every MET increase in oxygen uptake.Conclusions: Wrist-worn triaxial accelerometry reliably predicted energy expenditure during common physical activities <6 METs. More consistent correlations were found when the accelerometer was worn on the non-dominant wrist rather than the dominant wrist. [ABSTRACT FROM AUTHOR]- Published
- 2017
- Full Text
- View/download PDF
36. Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort.
- Author
-
Han, MeiLan K, Quibrera, Pedro M, Carretta, Elizabeth E, Barr, R Graham, Bleecker, Eugene R, Bowler, Russell P, Cooper, Christopher B, Comellas, Alejandro, Couper, David J, Curtis, Jeffrey L, Criner, Gerard, Dransfield, Mark T, Hansel, Nadia N, Hoffman, Eric A, Kanner, Richard E, Krishnan, Jerry A, Martinez, Carlos H, Pirozzi, Cheryl B, O'Neal, Wanda K, and Rennard, Stephen
- Subjects
OBSTRUCTIVE lung diseases patients ,HEALTH risk assessment ,DISEASE exacerbation - Abstract
Summary Background Present treatment strategies to stratify exacerbation risk in patients with chronic obstructive pulmonary disease (COPD) rely on a history of two or more events in the previous year. We aimed to understand year to year variability in exacerbations and factors associated with consistent exacerbations over time. Methods In this longitudinal, prospective analysis of exacerbations in the Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS) cohort, we analysed patients aged 40–80 years with COPD for whom 3 years of prospective data were available, identified through various means including care at academic and non-academic medical centres, word of mouth, and existing patient registries. Participants were enrolled in the study between Nov 12, 2010, and July 31, 2015. We classified patients according to yearly exacerbation frequency: no exacerbations in any year; one exacerbation in every year during 3 years of follow-up; and those with inconsistent exacerbations (individuals who had both years with exacerbations and years without during the 3 years of follow-up). Participants were characterised by the Global Initiative for Chronic Obstructive Lung Disease (GOLD) spirometric category (1–4) on the basis of post-bronchodilator FEV 1 . Stepwise logistic regression was used to compare factors associated with one or more acute exacerbations of COPD every year for 3 years versus no exacerbations in the same timeframe. Additionally, a stepwise zero-inflated negative binomial model was used to assess predictors of exacerbation count during follow-up in all patients with available data. Baseline symptom burden was assessed with the COPD assessment test. This trial is registered with ClinicalTrials.gov , number NCT01969344 . Findings 2981 patients were enrolled during the study. 1843 patients had COPD, of which 1105 patients had 3 years of complete, prospective follow-up data. 538 (49%) of 1105 patients had at least one acute exacerbation during the 3 years of follow-up, whereas 567 (51%) had none. 82 (7%) of 1105 patients had at least one acute exacerbation each year, whereas only 23 (2%) had two or more acute exacerbations in each year. An inconsistent pattern (both years with and without acute exacerbations) was common (456 [41%] of the group), particularly among GOLD stages 3 and 4 patients (256 [56%] of 456). In logistic regression, consistent acute exacerbations (≥1 event per year for 3 years) were associated with higher baseline symptom burden, previous exacerbations, greater evidence of small airway abnormality on CT, lower interleukin-15 concentrations, and higher interleukin-8 concentrations, than were no acute exacerbations. Interpretation Although acute exacerbations are common, the exacerbation status of most individuals varies markedly from year to year. Among patients who had any acute exacerbation over 3 years, very few repeatedly had two or more events per year. In addition to symptoms and history of exacerbations in the year before study enrolment, we identified several novel biomarkers associated with consistent exacerbations, including CT-defined small airway abnormality, and interleukin-15 and interleukin-8 concentrations. Funding National Institutes of Health, and National Heart, Lung, and Blood Institute. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
37. 7-Substituted 2-Nitro-5,6-dihydroimidazo[2,1-b][1,3]oxazines: Novel Antitubercular Agents Lead to a New Preclinical Candidate for Visceral Leishmaniasis.
- Author
-
Thompson, Andrew M., O'Connor, Patrick D., Marshall, Andrew J., Yardley, Vanessa, Louis Maes, Gupta, Suman, Launay, Delphine, Braillard, Stephanie, Chatelain, Eric, Franzblau, Scott G., Baojie Wan, Yuehong Wang, Zhenkun Ma, Cooper, Christopher B., and Denny, William A.
- Published
- 2017
- Full Text
- View/download PDF
38. Bronchodilator Responsiveness in Tobacco-Exposed People With or Without COPD
- Author
-
Fortis, Spyridon, Quibrera, Pedro M., Comellas, Alejandro P., Bhatt, Surya P., Tashkin, Donald P., Hoffman, Eric A., Criner, Gerard J., Han, MeiLan K., Barr, R. Graham, Arjomandi, Mehrdad, Dransfield, Mark B., Peters, Stephen P., Dolezal, Brett A., Kim, Victor, Putcha, Nirupama, Rennard, Stephen I., Paine, Robert, Kanner, Richard E., Curtis, Jeffrey L., Bowler, Russell P., Martinez, Fernando J., Hansel, Nadia N., Krishnan, Jerry A., Woodruff, Prescott G., Barjaktarevic, Igor Z., Couper, David, Anderson, Wayne H., Cooper, Christopher B., Alexis, Neil E., Anderson, Wayne H., Arjomandi, Mehrdad, Barjaktarevic, Igor, Barr, R. Graham, Basta, Patricia, Bateman, Lori A., Bhatt, Surya P., Bleecker, Eugene R., Boucher, Richard C., Bowler, Russell P., Christenson, Stephanie A., Comellas, Alejandro P., Cooper, Christopher B., Couper, David J., Criner, Gerard J., Crystal, Ronald G., Curtis, Jeffrey L., Doerschuk, Claire M., Dransfield, Mark T., Drummond, Brad, Freeman, Christine M., Galban, Craig, Han, MeiLan K., Hansel, Nadia N., Hastie, Annette T., Hoffman, Eric A., Huang, Yvonne, Kaner, Robert J., Kanner, Richard E., Kleerup, Eric C., Krishnan, Jerry A., LaVange, Lisa M., Lazarus, Stephen C., Martinez, Fernando J., Meyers, Deborah A., Moore, Wendy C., Newell, John D., Paine, Robert, Paulin, Laura, Peters, Stephen P., Pirozzi, Cheryl, Putcha, Nirupama, Oelsner, Elizabeth C., O’Neal, Wanda K., Ortega, Victor E., Raman, Sanjeev, Rennard, Stephen I., Tashkin, Donald P., Wells, J. Michael, Wise, Robert A., and Woodruff, Prescott G.
- Abstract
Bronchodilator responsiveness (BDR) in obstructive lung disease varies over time and may be associated with distinct clinical features.
- Published
- 2023
- Full Text
- View/download PDF
39. Diagnostic Value of Quantitative Chest CT Scan in a Case of Spontaneous Pneumothorax
- Author
-
Melamed, Kathryn H., Abtin, Fereidoun, Barjaktarevic, Igor, and Cooper, Christopher B.
- Abstract
An 18-year-old woman with no previous medical history presented to an outside hospital facility with acute chest pain. She had mild shortness of breath, particularly with exertion, for the prior 2 months.
- Published
- 2017
- Full Text
- View/download PDF
40. Reduced COPD Exacerbation Risk Correlates With Improved FEV1
- Author
-
Zider, Alexander D., Wang, Xiaoyan, Buhr, Russell G., Sirichana, Worawan, Barjaktarevic, Igor Z., and Cooper, Christopher B.
- Abstract
The mechanism by which various classes of medication reduce COPD exacerbation risk remains unknown. We hypothesized a correlation between reduced exacerbation risk and improvement in airway patency as measured according to FEV1.
- Published
- 2017
- Full Text
- View/download PDF
41. Discovery of Novel Oral Protein Synthesis Inhibitors of Mycobacterium tuberculosisThat Target Leucyl-tRNA Synthetase
- Author
-
Palencia, Andrés, Li, Xianfeng, Bu, Wei, Choi, Wai, Ding, Charles Z., Easom, Eric E., Feng, Lisa, Hernandez, Vincent, Houston, Paul, Liu, Liang, Meewan, Maliwan, Mohan, Manisha, Rock, Fernando L., Sexton, Holly, Zhang, Suoming, Zhou, Yasheen, Wan, Baojie, Wang, Yuehong, Franzblau, Scott G., Woolhiser, Lisa, Gruppo, Veronica, Lenaerts, Anne J., O'Malley, Theresa, Parish, Tanya, Cooper, Christopher B., Waters, M. Gerard, Ma, Zhenkun, Ioerger, Thomas R., Sacchettini, James C., Rullas, Joaquín, Angulo-Barturen, Iñigo, Pérez-Herrán, Esther, Mendoza, Alfonso, Barros, David, Cusack, Stephen, Plattner, Jacob J., and Alley, M. R. K.
- Abstract
ABSTRACTThe recent development and spread of extensively drug-resistant and totally drug-resistant resistant (TDR) strains of Mycobacterium tuberculosishighlight the need for new antitubercular drugs. Protein synthesis inhibitors have played an important role in the treatment of tuberculosis (TB) starting with the inclusion of streptomycin in the first combination therapies. Although parenteral aminoglycosides are a key component of therapy for multidrug-resistant TB, the oxazolidinone linezolid is the only orally available protein synthesis inhibitor that is effective against TB. Here, we show that small-molecule inhibitors of aminoacyl-tRNA synthetases (AARSs), which are known to be excellent antibacterial protein synthesis targets, are orally bioavailable and effective against M. tuberculosisin TB mouse infection models. We applied the oxaborole tRNA-trapping (OBORT) mechanism, which was first developed to target fungal cytoplasmic leucyl-tRNA synthetase (LeuRS), to M. tuberculosisLeuRS. X-ray crystallography was used to guide the design of LeuRS inhibitors that have good biochemical potency and excellent whole-cell activity against M. tuberculosis. Importantly, their good oral bioavailability translates into in vivoefficacy in both the acute and chronic mouse models of TB with potency comparable to that of the frontline drug isoniazid.
- Published
- 2016
- Full Text
- View/download PDF
42. Effect of Exercise Training on Striatal Dopamine D2/D3 Receptors in Methamphetamine Users during Behavioral Treatment
- Author
-
Robertson, Chelsea L, Ishibashi, Kenji, Chudzynski, Joy, Mooney, Larissa J, Rawson, Richard A, Dolezal, Brett A, Cooper, Christopher B, Brown, Amira K, Mandelkern, Mark A, and London, Edythe D
- Abstract
Methamphetamine use disorder is associated with striatal dopaminergic deficits that have been linked to poor treatment outcomes, identifying these deficits as an important therapeutic target. Exercise attenuates methamphetamine-induced neurochemical damage in the rat brain, and a preliminary observation suggests that exercise increases striatal D2/D3 receptor availability (measured as nondisplaceable binding potential (BPND)) in patients with Parkinson’s disease. The goal of this study was to evaluate whether adding an exercise training program to an inpatient behavioral intervention for methamphetamine use disorder reverses deficits in striatal D2/D3 receptors. Participants were adult men and women who met DSM-IV criteria for methamphetamine dependence and were enrolled in a residential facility, where they maintained abstinence from illicit drugs of abuse and received behavioral therapy for their addiction. They were randomized to a group that received 1 h supervised exercise training (n=10) or one that received equal-time health education training (n=9), 3 days/week for 8 weeks. They came to an academic research center for positron emission tomography (PET) using [18F]fallypride to determine the effects of the 8-week interventions on striatal D2/D3 receptor BPND. At baseline, striatal D2/D3 BPNDdid not differ between groups. However, after 8 weeks, participants in the exercise group displayed a significant increase in striatal D2/D3 BPND, whereas those in the education group did not. There were no changes in D2/D3 BPNDin extrastriatal regions in either group. These findings suggest that structured exercise training can ameliorate striatal D2/D3 receptor deficits in methamphetamine users, and warrants further evaluation as an adjunctive treatment for stimulant dependence.
- Published
- 2016
- Full Text
- View/download PDF
43. Diffusing Capacity for Carbon Monoxide Correlates Best With Tissue Volume From Quantitative CT Scanning Analysis
- Author
-
Barjaktarevic, Igor, Springmeyer, Steven, Gonzalez, Xavier, Sirokman, William, Coxson, Harvey O., and Cooper, Christopher B.
- Abstract
Quantitative analysis of high-resolution chest CT scan (QCT) is an established method for determining the severity and distribution of lung parenchymal destruction in patients with emphysema. Diffusing capacity of the lung for carbon monoxide (Dlco) is a traditional physiologic measure of emphysema severity and is probably influenced more by destruction of the alveolar capillary bed than by membrane diffusion per se. We reasoned that Dlcoshould correlate with tissue volume from QCT.
- Published
- 2015
- Full Text
- View/download PDF
44. Developmentof Mycobacterium tuberculosisWholeCell Screening Hits as Potential Antituberculosis Agents.
- Author
-
Cooper, Christopher B.
- Published
- 2013
- Full Text
- View/download PDF
45. Validity of Two Commercial Grade Bioelectrical Impedance Analyzers for Measurement of Body Fat Percentage.
- Author
-
Dolezal, Brett A., Lau, Michael J., Abrazado, Marlon, Storer, Thomas W., and Cooper, Christopher B.
- Subjects
BIOELECTRIC impedance ,BODY composition ,DUAL-energy X-ray absorptiometry ,PHYSIOLOGISTS ,FAT measurement ,EXERCISE physiology - Abstract
The purpose of this study was to validate the assessment of %Fat measured by two commercial grade BIA devices against the gold standard of dual x-ray absorptiometry Official Research Journal (DEXA). Twenty-one subjects were measured for %Fat using of the American Society of three devices: an octopolar, multi-frequency BIA device (BIA8, Exercise Physiologists BioSpace InBody R20); a quadripolar, single frequency BIA device (BIA4, Tanita BC-590BT); and a whole body DEXA ISSN 1097-9751 (Hologic 4500). Mean ± SD differences in %Fat between the devices and DEXA were 0.14 ± 0.04 (P=0.80) (BIA8) and 1.77 ± 0.54 (P=0.76) (BIA4). Correlations with DEXA were r=0.98 (BIA8) and r=0.92 (BIA4). Bland-Altman analyses revealed a systematic bias for both BIA instruments vs. DEXA in which %Fat was underestimated in leaner subjects and overestimated in fatter subjects. All subjects had individual differences of =±3.0 %Fat for BIA8 vs. DEXA while 43% had differences of =3.0 %Fat for BIA4 vs. DEXA. Our data suggest that the use of an octopolar BIA device yields more than twice as many subjects within a ±3% error compared with BIA4; a value that might be considered appropriate for clinical use. [ABSTRACT FROM AUTHOR]
- Published
- 2013
46. Eight Weeks of Exercise Training Improves Fitness Measures in Methamphetamine-Dependent Individuals in Residential Treatment.
- Author
-
Dolezal, Brett A., Chudzynski, Joy, Storer, Thomas W., Abrazado, Marlon, Penate, Jose, Mooney, Larissa, Dickerson, Daniel, Rawson, Richard A., and Cooper, Christopher B.
- Abstract
The article reports on research which investigated the feasibility and efficacy of an eight week endurance and resistance training program and its ability to improve fitness in methamphetamine dependent individuals in residential treatment. Researchers evaluated 39 dependent subjects. They found that the training led to improved fitness levels and was feasible.
- Published
- 2013
- Full Text
- View/download PDF
47. Identification of LessLipophilic Riminophenazine Derivatives for the Treatment of Drug-ResistantTuberculosis.
- Author
-
Zhang, Dongfeng, Lu, Yu, Liu, Kai, Liu, Binna, Wang, Jingbin, Zhang, Gang, Zhang, Hao, Liu, Yang, Wang, Bin, Zheng, Meiqin, Fu, Lei, Hou, Yanyan, Gong, Ningbo, Lv, Yang, Li, Chun, Cooper, Christopher B., Upton, Anna M., Yin, Dali, Ma, Zhenkun, and Huang, Haihong
- Published
- 2012
- Full Text
- View/download PDF
48. Diphenylpyridylethanamine(DPPE) Derivatives as Cholesteryl Ester Transfer Protein (CETP) Inhibitors.
- Author
-
Harikrishnan, Lalgudi S., Finlay, Heather J., Qiao, Jennifer X., Kamau, Muthoni G., Jiang, Ji, Wang, Tammy C., Li, James, Cooper, Christopher B., Poss, Michael A., Adam, Leonard P., Taylor, David S., Chen, Alice Ye A., Yin, Xiaohong, Sleph, Paul G., Yang, Richard Z., Sitkoff, Doree F., Galella, Michael A., Nirschl, David S., Van Kirk, Katy, and Miller, Arthur V.
- Published
- 2012
- Full Text
- View/download PDF
49. Effective Inspired Oxygen Concentration Measured Via Transtracheal and Oral Gas Analysis.
- Author
-
Markovitz, Gerald H., Colthurst, James, Storer, Thomas W., and Cooper, Christopher B.
- Subjects
OXYGEN therapy ,PHYSIOLOGICAL transport of oxygen ,HYPOXEMIA ,CATHETERS ,LUNG diseases ,CHRONIC diseases - Abstract
BACKGROUND: The fraction of inspired oxygen (F
IO ) is quoted for different oxygen delivery systems, but variations in inspiratory flow and tidal volume make precise measurement difficult. We developed a reliable method of measuring the effective F2 IO in patients receiving supplemental oxygen. METHODS: Ten subjects with chronic hypoxemia breathed through a mouthpiece with a sampling probe connected to a mass spectrometer. Four of the 10 subjects had transtracheal catheters that allowed direct sampling of tracheal gas. We used oxygen concentrations of 47% and 97%, and flow rates between 1 L/min and 8 L/min. We also compared oxygen delivery via nasal cannula and transtracheal catheter. Effective F2 IO was derived from plots of the fractional concentrations of carbon dioxide versus oxygen. RESULTS: We found excellent correlation between the effective F2 IO values from tracheal and oral sampling (r = 0.960, P < .001). With 97% oxygen via nasal cannula, effective F2 IO increased by 2.5% per liter of increased flow (P < .001); effective F2 IO reached 32.7% at 5 L/min while P2 aO increased by 12 mm Hg per liter of increased flow. In 4 subjects with a transtracheal catheter, effective F2 IO increased 5.0% (P < .001) per liter of increased flow, and P2 aO increased by 13 mm Hg per liter of increased flow, whereas in the same 4 subjects using nasal cannula for oxygen delivery, P2 aO increased by only 6 mm Hg per liter of increased flow. CONCLUSIONS: Exhaled gas sampled at the mouth accurately reflected the effective F2 IO in the trachea. In relation to inspired oxygen flow, the effective F2 IO was lower than is conventionally thought. Compared to nasal cannula, transtracheal catheter approximately doubled the effective F2 IO at a given flow rate. Accurate knowledge of F2 IO should aid clinicians in managing patients with acute and chronic lung diseases. [ABSTRACT FROM AUTHOR]2 - Published
- 2010
50. Airflow obstruction and exercise.
- Author
-
Cooper, Christopher B.
- Abstract
Summary: The primary abnormality in chronic obstructive pulmonary disease (COPD) is chronic airway inflammation which results in airflow limitation. Disease progression is usually depicted as an accelerated decline in FEV
1 over time. However, COPD patients also manifest progressive static hyperinflation due to the combined effects of reduced lung elastic recoil and increased airway resistance. Superimposed on static hyperinflation are further increases in operational lung volumes (dynamic hyperinflation) brought on during exercise, exacerbations or tachypnea. An important consequence of exertional dyspnea is activity limitation. COPD patients have been shown to spend only a third of the day walking or standing compared with age-matched healthy individuals who spend more than half of their time in these activities. Furthermore, the degree of activity limitation measured by an accelerometer worsens with disease progression. COPD patients have been shown to have an accelerated loss of aerobic capacity (VO2 max) and this correlates with mortality just as is seen with hypertension, diabetes and obesity. Thus physical inactivity is an important therapeutic target in COPD. Summarizing; airflow obstruction leads to progressive hyperinflation, activity limitation, physical deconditioning and other comorbidities that characterize the COPD phenotype. Targeting the airflow obstruction with long-acting bronchodilator therapy in conjunction with a supervised exercise prescription is currently the most effective therapeutic intervention in earlier COPD. Other important manifestations of skeletal muscle dysfunction include muscle atrophy and weakness. These specific problems are best addressed with resistance training with consideration of anabolic supplementation. [Copyright &y& Elsevier]- Published
- 2009
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.